The University of Texas Health Science Center at Houston (UTHealth) has announced more details on its statewide seroprevalance study on the human antibody response to the coronavirus that causes COVID-19.
Part of the study, called Texas Coronavirus Antibody Response Survey, or Texas CARES, is an online survey to estimate how many people in Texas have COVID-19 antibodies and how long those antibodies last. The study also seeks to identify the characteristics of those who do and don’t develop antibodies.
Researchers have asked physicians to encourage patients to participate in the study.
“The survey team is looking to enroll a diverse population of participants to gather more insight on why some individuals infected with the virus are asymptomatic and if that affects their antibody response,” UTHealth said in a statement. “Those who have tested positive, negative, or have never been tested for COVID-19 are eligible to enroll in this assessment.”
Researchers are looking specifically for participants between 5 and 17 years old as well as teachers and education professionals; retail, business, or service sector employees; and community clinic patients.
UTHealth has partnered with the Texas Department of State Health Services (DSHS) to develop and fund the study, in which participants will receive three free antibody tests at local labs between September 2020 and July 2021.
More information, including details about how to participate, can be found on the survey’s website, Facebook page, or in this video.
UTHealth also has created a poster – available in English and Spanish – with more information on the study that you can print out and post in your practice, or post to your social media accounts.
As always, find the latest news, resources, and government guidance on the coronavirus outbreak by visiting TMA’s COVID-19 Resource Center regularly.
Last Updated On
October 20, 2020
Originally Published On
October 20, 2020